Actively Recruiting
Low Pressure Pneumoperitoneum and Postoperative Ileus
Led by Ohio State University · Updated on 2025-11-03
125
Participants Needed
2
Research Sites
177 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators are testing the hypothesis that lower pressure pneumoperitoneum during laparoscopic large bowel surgery protects the bowel from postoperative ileus and bowel dysfunction leading to faster recovery and discharge from the hospital. Our study will focus on the effects of high or low intraperitoneal pressure as well as pressure variations on the course of postoperative ileus, time to hospital discharge, and postoperative gastrointestinal dysfunction in adult patients undergoing laparoscopic large bowel resection (i.e., sigmoidectomy and right colectomy). A randomized parallel group study will be conducted involving 5 arms of surgical patients to test whether differences on postoperative ileus outcome parameters occur between high (15 mm Hg) and low pressure pneumoperitoneum (8-12 mm Hg), as well as whether there are differences between the 2 insufflation devices that provide constant or variable intrabdominal pressure throughout the laparoscopic surgery. For high pressure pneumoperitoneum, either neostigmine or sugammadex are used for reversal of moderate neuromuscular blockade. For low pressure pneumoperitoneum, sugammadex is used for reversal of deep neuromuscular blockade. The investigators plan to use 2 types of gas insufflation devices, one of which will provide a relatively stable pressure level throughout surgery (AirSeal® device), and the second one will provide a more variable pressure (Olympus standard insufflation device). Using both pressure modalities, the investigators will study the effects of different pressure characteristics on the course of postoperative ileus, duration of in-hospital treatment, pain level, and the stability of hemodynamic and respiratory parameters during surgery. Changes in intrabdominal pressure during the surgery will be monitored and recorded using a custom software for later analysis of fluctuations in pressure to relate them to outcomes. Other parameters will be obtained from EPIC (IHIS) medical charts. In addition, clinical data on postoperative ileus will be correlated with experimental outcomes from in vitro exploratory studies done using human samples of peritoneal lavage fluid, serum, and a small portion of the surgically removed bowel from each patient (that is otherwise discarded). A panel of inflammatory markers will be analyzed and biochemical, imaging, histological, immunochemical, molecular signaling, and glial activation studies will be done to evaluate the potential mechanisms of dysfunction associated with postoperative ileus.
CONDITIONS
Official Title
Low Pressure Pneumoperitoneum and Postoperative Ileus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients over 18 years old of any gender who consent to participate
- Patients undergoing laparoscopic right hemicolectomy to remove tumors
- Patients undergoing laparoscopic sigmoid resection to remove polyps, diverticula, or tumors
You will not qualify if you...
- History of inflammatory bowel disease
- History of intestinal ischemia
- History of intestinal adhesions or adhesive disease
- History of bowel resection or major abdominal surgery (excluding appendectomy or hernia repair)
- Use of epidural catheters for postoperative pain control during the study period
- Significant acid-base or electrolyte imbalance before surgery
- Allergy or contraindication to rocuronium or sugammadex
- Medical conditions or medications that affect the duration of rocuronium
- Significant other comorbid conditions as determined by study personnel
- Use of drugs that may alter postoperative ileus
- Prisoners or pregnant patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States, 43210
Not Yet Recruiting
2
Tzagournis Medical Research Facility
Columbus, Ohio, United States, 43210
Actively Recruiting
Research Team
F
Fedias L Christofi, Ph.D., AGAF
CONTACT
A
Alberto Uribe, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here